Skip to main content
Journal ArticleOPEN ACCESS

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

OncoImmunology (2015) 4(6)
DOI: 10.1080/2162402X.2015.1006088
27Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

γδ T cell-based immunotherapeutic strategies in cancer patients are as yet of limited success. Drugs targeting epigenetic mechanisms including histone acetylation and DNA methylation trigger cell death in tumor cells but in addition have immunomodulatory activity. Here, we discuss the potential benefit of combining both strategies in cancer immunotherapy.

Author supplied keywords

References Powered by Scopus

Chromatin Modifications and Their Function

Cell
8838Citations
N/AReaders
Get full text

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

Nature
1377Citations
N/AReaders
Get full text

Six-of-the-best: Unique contributions of γδ T cells to immunology

Nature Reviews Immunology
993Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

Improving the efficiency of Vγ9Vδ2 T-cell immunotherapy in cancer

Frontiers in Immunology
120Citations
N/AReaders
Get full text

The ovarian cancer tumor immune microenvironment (Time) as target for therapy: A focus on innate immunity cells as therapeutic effectors

International Journal of Molecular Sciences
91Citations
N/AReaders
Get full text

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

Journal of Hematology and Oncology
90Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bhat, J., & Kabelitz, D. (2015). γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy? OncoImmunology, 4(6). https://doi.org/10.1080/2162402X.2015.1006088

Readers over time

‘16‘17‘18‘19‘20‘23‘24‘2502468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

75%

Researcher 2

17%

Lecturer / Post doc 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

33%

Immunology and Microbiology 4

33%

Agricultural and Biological Sciences 3

25%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Save time finding and organizing research with Mendeley

Sign up for free
0